Larona 15 mg želučanootporne kapsule
| Name | Larona 15 mg želučanootporne kapsule |
|---|---|
| Former Name | Larona 15 mg kapsule |
| Marketing Authorisation Number | HR-H-321273562 |
| Active Substance | lanzoprazol |
| Composition | jedna kapsula sadrži 15 mg lanzoprazola |
| Pharmaceutical Form | želučanootporna kapsula, tvrda |
| Packaging [MA Number for Packaging] | 28 kapsula u bočici, u kutiji [HR-H-321273562-01] 28 kapsula u blisteru, u kutiji [HR-H-321273562-02] |
| Manufacturer | Jadran Galenski laboratorij d.d., Rijeka, Hrvatska Teva Pharma S.L.U., Zaragoza, Španjolska |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 08.11.2017 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/33 |
| Registration Number | 381-12-01/30-17-07 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | A02BC03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
